Correction to: Gender differences in nerve regeneration after sciatic nerve injury and repair in healthy and in type 2 diabetic Goto-Kakizaki rats (BMC Neuroscience, (2014), 15, 1, (107), 10.1186/1471-2202-15-107);Gender differences in nerve regeneration after sciatic nerve injury and repair in healthy and in type 2 diabetic Goto-Kakizaki rats

BMC Neuroscience

Volumn 15, Issue 1, 2014, Pages

  Stenberg, Lena ^a   Dahlin, Lars B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Diabetes; Gender differences; Nerve regeneration; Nerve repair; Neuropathy; Schwann cells

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; CASPASE 3; ATF3 PROTEIN, RAT; CASP3 PROTEIN, RAT; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; GLUCOSE BLOOD LEVEL; GOTO KAKIZAKI RAT; IMMUNOHISTOCHEMISTRY; MALE; NERVE REGENERATION; NEUROFILAMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; SCHWANN CELL; SCIATIC NERVE; SCIATIC NERVE INJURY; SEX DIFFERENCE; ANIMAL; DIABETIC NEPHROPATHY; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; NERVE FIBER; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SCIATIC NEUROPATHY; SEXUAL DEVELOPMENT; WEIGHT GAIN; WISTAR RAT;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; AXONS; BLOOD GLUCOSE; CASPASE 3; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; FEMALE; MALE; NERVE REGENERATION; RATS; RATS, WISTAR; SCHWANN CELLS; SCIATIC NEUROPATHY; SEX CHARACTERISTICS; WEIGHT GAIN;

EID: 84907280999     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/s12868-020-00594-0     Document Type: Erratum

References (50)

1. Aaberg ML, Burch DM, Hud ZR, Zacharias MP. Gender differences in the onset of diabetic neuropathy. J Diabetes Complications 2008, 22:83-87. 10.1016/j.jdiacomp.2007.06.009, 18280437.
2. Sima AA. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 2003, 60:2445-2464. 10.1007/s00018-003-3084-x, 14625688.
3. Pesaresi M, Maschi O, Giatti S, Garcia-Segura LM, Caruso D, Melcangi RC. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm Behav 2010, 57:46-55. 10.1016/j.yhbeh.2009.04.008, 19422828.
4. Sharma N, Marzo SJ, Jones KJ, Foecking EM. Electrical stimulation and testosterone differentially enhance expression of regeneration-associated genes. Exp Neurol 2010, 223:183-191. 10.1016/j.expneurol.2009.04.031, 19427307.
5. Melcangi RC, Giatti S, Pesaresi M, Calabrese D, Mitro N, Caruso D, Garcia-Segura LM. Role of neuroactive steroids in the peripheral nervous system. Front Endocrinol (Lausanne) 2011, 2:104. 3356101, 22654839.
6. Stenberg L, Kanje M, Dolezal K, Dahlin LB. Expression of activating transcription factor 3 (ATF 3) and caspase 3 in Schwann cells and axonal outgrowth after sciatic nerve repair in diabetic BB rats. Neurosci Lett 2012, 515:34-38. 10.1016/j.neulet.2012.03.011, 22446192.
7. Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, Yonenobu K, Ochi T, Noguchi K. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: A novel neuronal marker of nerve injury. Mol Cell Neurosci 2000, 15:170-182. 10.1006/mcne.1999.0814, 10673325.
8. Kataoka K, Kanje M, Dahlin LB. Induction of activating transcription factor 3 after different sciatic nerve injuries in adult rats. Scand J Plast Reconstr Surg Hand Surg 2007, 41:158-166. 10.1080/02844310701318288, 17701728.
9. Saito H, Dahlin LB. Expression of ATF3 and axonal outgrowth are impaired after delayed nerve repair. BMC Neurosci 2008, 9:88. 10.1186/1471-2202-9-88, 2556676, 18801180.
10. Stenberg L, Kanje M, Martensson L, Dahlin LB. Injury-induced activation of ERK 1/2 in the sciatic nerve of healthy and diabetic rats. Neuroreport 2011, 22:73-77. 10.1097/WNR.0b013e328342986c, 21150475.
11. Nishida N, Yamagishi S, Mizukami H, Yagihashi S. Impaired nerve fiber regeneration in axotomized peripheral nerves in streptozotocin-diabetic rats. J Diabetes Investig 2013, 4:533-539. 10.1111/jdi.12115, 4020247, 24843706.
12. Dey I, Midha N, Singh G, Forsyth A, Walsh SK, Singh B, Kumar R, Toth C, Midha R. Diabetic Schwann cells suffer from nerve growth factor and neurotrophin-3 underproduction and poor associability with axons. Glia 2013, 61:1990-1999. 10.1002/glia.22570, 24123456.
13. Salles GS, Faria JC, Busnardo FF, Gemperli R, Ferreira MC. Evaluation of nerve regeneration in diabetic rats. Acta Cir Bras 2013, 28:509-517. 10.1590/S0102-86502013000700006, 23842932.
14. Yao CH, Chang RL, Chang SL, Tsai CC, Tsai FJ, Chen YS. Electrical stimulation improves peripheral nerve regeneration in streptozotocin-induced diabetic rats. J Trauma Acute Care Surg 2012, 72:199-205.
15. Portha B, Lacraz G, Kergoat M, Homo-Delarche F, Giroix MH, Bailbe D, Gangnerau MN, Dolz M, Tourrel-Cuzin C, Movassat J. The GK rat beta-cell: a prototype for the diseased human beta-cell in type 2 diabetes?. Mol Cell Endocrinol 2009, 297:73-85. 10.1016/j.mce.2008.06.013, 18640239.
16. Meek MF, Koning MA, Nicolai JP, Gramsbergen A. Rehabilitation strategy using enhanced housing environment during neural regeneration. J Neurosci Methods 2004, 136:179-185. 10.1016/j.jneumeth.2004.01.005, 15183269.
17. Yu WH. Sex difference in the regeneration of the hypoglossal nerve in rats. Brain Res 1982, 238:404-406. 10.1016/0006-8993(82)90114-7, 7093660.
18. Yu WH, McGinnis MY. Androgen receptors in cranial nerve motor nuclei of male and female rats. J Neurobiol 2001, 46:1-10. 10.1002/1097-4695(200101)46:1<1::AID-NEU1>3.0.CO;2-U, 11108611.
19. Roglio I, Bianchi R, Gotti S, Scurati S, Giatti S, Pesaresi M, Caruso D, Panzica GC, Melcangi RC. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience 2008, 155:673-685. 10.1016/j.neuroscience.2008.06.034, 18625290.
20. Schumacher M, Guennoun R, Stein DG, De Nicola AF. Progesterone: therapeutic opportunities for neuroprotection and myelin repair. Pharmacol Ther 2007, 116:77-106. 10.1016/j.pharmthera.2007.06.001, 17659348.
21. Schumacher M, Guennoun R, Mercier G, Desarnaud F, Lacor P, Benavides J, Ferzaz B, Robert F, Baulieu EE. Progesterone synthesis and myelin formation in peripheral nerves. Brain Res Brain Res Rev 2001, 37:343-359. 10.1016/S0165-0173(01)00139-4, 11744099.
22. Chavez-Delgado ME, Gomez-Pinedo U, Feria-Velasco A, Huerta-Viera M, Castaneda SC, Toral FA, Parducz A, Anda SL, Mora-Galindo J, Garcia-Estrada J. Ultrastructural analysis of guided nerve regeneration using progesterone- and pregnenolone-loaded chitosan prostheses. J Biomed Mater Res B Appl Biomater 2005, 74:589-600.
23. Haastert-Talini K, Geuna S, Dahlin LB, Meyer C, Stenberg L, Freier T, Heimann C, Barwig C, Pinto LF, Raimondo S, Gambarotta G, Samy SR, Sousa N, Salgado AJ, Ratzka A, Wrobel S, Grothe C. Chitosan tubes of varying degrees of acetylation for bridging peripheral nerve defects. Biomaterials 2013, 34:9886-9904. 10.1016/j.biomaterials.2013.08.074, 24050875.
24. Pesaresi M, Giatti S, Cavaletti G, Abbiati F, Calabrese D, Lombardi R, Bianchi R, Lauria G, Caruso D, Garcia-Segura LM, Melcangi RC. Sex-dimorphic effects of dehydroepiandrosterone in diabetic neuropathy. Neuroscience 2011, 199:401-409.
25. Caruso D, Pesaresi M, Maschi O, Giatti S, Garcia-Segura LM, Melcangi RC. Effect of short-and long-term gonadectomy on neuroactive steroid levels in the central and peripheral nervous system of male and female rats. J Neuroendocrinol 2010, 22:1137-1147. 10.1111/j.1365-2826.2010.02064.x, 20819120.
26. Kamenov ZA, Parapunova RA, Georgieva RT. Earlier development of diabetic neuropathy in men than in women with type 2 diabetes mellitus. Gend Med 2010, 7:600-615. 10.1016/j.genm.2010.11.001, 21195360.
27. Callaghan B, Feldman E. The metabolic syndrome and neuropathy: therapeutic challenges and opportunities. Ann Neurol 2013, 74:397-403. 3881591, 23929529.
28. Callaghan BC, Hur J, Feldman EL. Diabetic neuropathy: one disease or two?. Curr Opin Neurol 2012, 25:536-541. 10.1097/WCO.0b013e328357a797, 22892951.
29. Caruso D, Scurati S, Maschi O, De Angelis L, Roglio I, Giatti S, Garcia-Segura LM, Melcangi RC. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem Int 2008, 52:560-568. 10.1016/j.neuint.2007.06.004, 17686551.
30. Leonelli E, Bianchi R, Cavaletti G, Caruso D, Crippa D, Garcia-Segura LM, Lauria G, Magnaghi V, Roglio I, Melcangi RC. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 2007, 144:1293-1304. 10.1016/j.neuroscience.2006.11.014, 17187935.
31. Lindwall C, Dahlin L, Lundborg G, Kanje M. Inhibition of c-Jun phosphorylation reduces axonal outgrowth of adult rat nodose ganglia and dorsal root ganglia sensory neurons. Mol Cell Neurosci 2004, 27:267-279. 10.1016/j.mcn.2004.07.001, 15519242.
32. Saito H, Kanje M, Dahlin LB. Delayed nerve repair increases number of caspase 3 stained Schwann cells. Neurosci Lett 2009, 456:30-33. 10.1016/j.neulet.2009.03.075, 19429128.
33. Tsuda Y, Kanje M, Dahlin LB. Axonal outgrowth is associated with increased ERK 1/2 activation but decreased caspase 3 linked cell death in Schwann cells after immediate nerve repair in rats. BMC Neurosci 2011, 12:12. 10.1186/1471-2202-12-12, 3031266, 21251262.
34. Yang DP, Zhang DP, Mak KS, Bonder DE, Pomeroy SL, Kim HA. Schwann cell proliferation during Wallerian degeneration is not necessary for regeneration and remyelination of the peripheral nerves: axon-dependent removal of newly generated Schwann cells by apoptosis. Mol Cell Neurosci 2008, 38:80-88. 10.1016/j.mcn.2008.01.017, 2440648, 18374600.
35. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 1999, 6:347-363. 10.1006/nbdi.1999.0254, 10527803.
36. Vincent AM, Brownlee M, Russell JW. Oxidative stress and programmed cell death in diabetic neuropathy. Ann N Y Acad Sci 2002, 959:368-383.
37. Singh B, Xu Y, McLaughlin T, Singh V, Martinez JA, Krishnan A, Zochodne DW. Resistance to trophic neurite outgrowth of sensory neurons exposed to insulin. J Neurochem 2012, 121:263-276. 10.1111/j.1471-4159.2012.07681.x, 22303986.
38. von Herrath M, Nepom GT. Remodeling rodent models to mimic human type 1 diabetes. Eur J Immunol 2009, 39:2049-2054. 10.1002/eji.200939429, 19672901.
39. Yono M, Pouresmail M, Takahashi W, Flanagan JF, Weiss RM, Latifpour J. Effect of insulin treatment on tissue size of the genitourinary tract in BB rats with spontaneously developed and streptozotocin-induced diabetes. Naunyn Schmiedebergs Arch Pharmacol 2005, 372:251-255. 10.1007/s00210-005-0010-9, 16235050.
40. Ramanathan S, Poussier P. BB rat lyp mutation and Type 1 diabetes. Immunol Rev 2001, 184:161-171. 10.1034/j.1600-065x.2001.1840115.x, 12086310.
41. Sima AA, Sugimoto K. Experimental diabetic neuropathy: an update. Diabetologia 1999, 42:773-788. 10.1007/s001250051227, 10440118.
42. Batulevicius D, Frese T, Peschke E, Pauza DH, Batuleviciene V. Remodelling of the intracardiac ganglia in diabetic Goto-Kakizaki rats: an anatomical study. Cardiovasc Diabetol 2013, 12:85. 10.1186/1475-2840-12-85, 3688305, 23758627.
43. Nelander J, Speidel T, Bjorkman A, Dahlin LB. Vibration thresholds are increased at low frequencies in the sole of the foot in diabetes-a novel multi-frequency approach. Diabet Med 2012, 29:e449-e456. 10.1111/dme.12024, 22998552.
44. Dahlin E, Ekholm E, Gottsater A, Speidel T, Dahlin LB. Impaired vibrotactile sense at low frequencies in fingers in autoantibody positive and negative diabetes. Diabetes Res Clin Pract 2013, 100:e46-e50. 10.1016/j.diabres.2013.01.026, 23465366.
45. Dahlin LB, Granberg V, Rolandsson O, Rosen I, Dahlin E, Sundkvist G. Disturbed vibrotactile sense in finger pulps in patients with Type 1 diabetes-correlations with glycaemic level, clinical examination and electrophysiology. Diabet Med 2011, 28:1045-1052. 10.1111/j.1464-5491.2011.03328.x, 21843302.
46. Pourhamidi K, Dahlin LB, Boman K, Rolandsson O. Heat shock protein 27 is associated with better nerve function and fewer signs of neuropathy. Diabetologia 2011, 54:3143-3149. 10.1007/s00125-011-2303-5, 21909836.
47. Korngut L, Ma CH, Martinez JA, Toth CC, Guo GF, Singh V, Woolf CJ, Zochodne DW. Overexpression of human HSP27 protects sensory neurons from diabetes. Neurobiol Dis 2012, 47:436-443. 10.1016/j.nbd.2012.04.017, 3392489, 22569359.
48. Kamiya H, Zhangm W, Sima AA. Apoptotic stress is counterbalanced by survival elements preventing programmed cell death of dorsal root ganglions in subacute type 1 diabetic BB/Wor rats. Diabetes 2005, 54:3288-3295. 10.2337/diabetes.54.11.3288, 16249457.
49. Dahlin LB, Stenberg L, Luthman H, Thomsen NO. Nerve compression induces activating transcription factor 3 in neurons and Schwann cells in diabetic rats. Neuroreport 2008, 19:987-990. 10.1097/WNR.0b013e328302f4ec, 18521006.
50. Fisher RA. Combining independent tests of significance. Am Stat 1948, 2:30.